1. |
Jiang Y, Goldberg ID, Shi YE. Complex roles of tissue inhibitors of metalloproteinases in cancer[J].Oncogene, 2002; 21(14)∶2245.
|
2. |
赵 新, 张培瑞, 俞祥海, 等. 腺病毒介导TIMP2基因转染抑制大鼠腹主动脉细胞外基质降解的实验研究 [J]. 中国普外基础与临床杂志, 2007; 14(3)∶276.
|
3. |
Jia L, Zhou H, Wang S, et al. Deglycosylation of CD147 down-regulates Matrix Metalloproteinase-11 expression and the adhesive capability of murine hepatocarcinoma cell HcaF in vitro [J]. IUBMB Life, 2006; 58(4)∶209.
|
4. |
Sambrook J, Fritsch EF, Maniatis T Eds. Molecular cloning: A Laboratory Manual[M]. 2nd ed. New York: CHS press, 1989.
|
5. |
伍志坚, 吴小兵, 曹 晖, 等. 一种高效的重组腺伴随病毒载体生产系统 [J]. 中国科学(C辑), 2001; 31(5)∶423.
|
6. |
吴小兵, 董小岩, 伍志坚, 等. 一种快速高效分离和纯化腺病毒伴随病毒载体的方法 [J]. 科学通报, 2000; 45(19)∶2071.
|
7. |
Debelak D, Fisher J, Iuliano S, et al. Cation-exchange high-performance liquid chromatography of recombinant adeno-associated virus type 2[J]. J Chromatogr B Biomed Sci Appl, 2000; 740(2)∶195.
|
8. |
Matsumoto E, Nakatsukasa H, Nouso K, et al. Increased levels of tissue inhibitor of metalloproteinase-1 in human hepatocellular carcinoma [J]. Liver Int, 2004; 24(4)∶379.
|
9. |
Monahan PE, Samulski RJ, Tazelaar J, et al. Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia [J]. Gene Ther, 1998; 5(1)∶40.
|
10. |
Rabinowitz JE, Samulski RJ. Building a better vector: the manipulation of AAV virions[J]. Virology, 2000; 278(2)∶30111 Santat L, Paz H, Wong C, et al. Recombinant AAV2 transduction of primitive human hematopoietic stem cells capable of serial engraftment in immune-deficient mice [J]. Proc Natl Acad Sci USA, 2005; 102(31)∶11053.
|
11. |
刘自明, 严律南, 李馨筱. 包载携有HSVTK基因腺病毒PLG微球的制备 [J]. 中国普外基础与临床杂志, 2007; 14(4)∶399.
|
12. |
张明满, 李德华, 苟兴华, 等. 靶向肝癌细胞的重组腺相关病毒载体的构建 [J]. 中国普外基础与临床杂志, 2005; 12(2)∶142.
|
13. |
Hermonat PL, Quirk JG, Bishop BM, et al. The packaging capacity of adeno-associated virus (AAV) and the potential for wild-type-plus AAV gene therapy vectors [J]. FEBS Lett, 1997; 407(1)∶78.
|
14. |
Phillips MI. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension [J]. Hypertension, 1997; 29(1 Pt 2)∶177.
|
15. |
Grimm D, Kern A, Rittner K, et al. Novel tools for production and purification of recombinant adenoassociated virus vectors [J]. Hum Gene Ther, 1998; 9(18)∶2745.
|
16. |
Zolotukhin S, Byrne BJ, Mason E, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield [J]. Gene Ther, 1999; 6(6)∶973.
|
17. |
Clark KR, Liu X, McGrath JP, et al. Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses [J]. Hum Gene Ther, 1999; 10(6)∶1031.
|
18. |
夏 冬, 徐 亮, 万礼仪, 等. 重组腺病毒介导hTIMP1对人肝癌细胞系体外增殖的影响 [J]. 中国普外基础与临床杂志, 2007; 14(4)∶409.
|
19. |
伍志坚, 吴小兵, 侯云德. 系列腺病毒伴随病毒载体的构建及表达β-半乳糖苷酶的研究 [J]. 病毒学报, 2000; 16(1)∶1.
|